Zai Lab

ZLAB NASDAQ
33.73
+0.27
+0.81%
After Hours: 33.73 0 0.00% 16:25 08/16 EDT
Open
33.68
Prev Close
33.46
High
34.43
Low
33.44
Volume
357.21K
Avg Vol (3M)
206.96K
52 Week High
36.78
52 Week Low
14.29
% Turnover
0.61%
Market Cap
1.97B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Zai Lab ZLAB stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.
MORE >

Recently

Name
Price
%Change